Cargando…
Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer
The transcription factor Prdm16 functions as a potent suppressor of transforming growth factor-beta (TGF-β) signaling, whose inactivation is deemed essential to the progression of pancreatic ductal adenocarcinoma (PDAC). Using the KrasG12D-based mouse model of human PDAC, we surprisingly found that...
Autores principales: | Hurwitz, Eric, Parajuli, Parash, Ozkan, Seval, Prunier, Celine, Nguyen, Thien Ly, Campbell, Deanna, Friend, Creighton, Bryan, Allyn Austin, Lu, Ting-Xuan, Smith, Steven Christopher, Razzaque, Mohammed Shawkat, Xu, Keli, Atfi, Azeddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999015/ https://www.ncbi.nlm.nih.gov/pubmed/36828547 http://dx.doi.org/10.1083/jcb.202203036 |
Ejemplares similares
-
Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
por: Parajuli, Parash, et al.
Publicado: (2020) -
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma
por: Ramakrishnan, Gopalakrishnan, et al.
Publicado: (2022) -
Regulatory Role of the Transcription Factor Twist1 in Cancer-Associated Muscle Cachexia
por: Razzaque, Mohammed S., et al.
Publicado: (2020) -
TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma
por: Razzaque, Mohammed S., et al.
Publicado: (2020) -
Editorial: Value-based nutritional intervention to reduce the progression of chronic human diseases
por: Razzaque, Mohammed S., et al.
Publicado: (2023)